Eledon Pharmaceuticals Inc (NASDAQ: ELDN) kicked off on Monday, up 11.81% from the previous trading day, before settling in for the closing price of $1.44. Over the past 52 weeks, ELDN has traded in a range of $1.35-$5.08.
Healthcare Sector giant saw their annual sales surged by 50.24% over the last five years. While this was happening, its average annual earnings per share was recorded -0.76%. With a float of $68.73 million, this company’s outstanding shares have now reached $75.08 million.
Eledon Pharmaceuticals Inc (ELDN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Eledon Pharmaceuticals Inc is 8.46%, while institutional ownership is 43.64%.
Eledon Pharmaceuticals Inc (ELDN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.95 earnings per share (EPS), lower than consensus estimate (set at -0.33) by -0.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.26% during the next five years compared to 50.24% growth over the previous five years of trading.
Eledon Pharmaceuticals Inc (NASDAQ: ELDN) Trading Performance Indicators
Take a look at Eledon Pharmaceuticals Inc’s (ELDN) current performance indicators. Last quarter, stock had a quick ratio of 6.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.20, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.90 in one year’s time.
Technical Analysis of Eledon Pharmaceuticals Inc (ELDN)
Analysing the last 5-days average volume posted by the [Eledon Pharmaceuticals Inc, ELDN], we can find that recorded value of 3.72 million was better than the volume posted last year of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 18.60%.
During the past 100 days, Eledon Pharmaceuticals Inc’s (ELDN) raw stochastic average was set at 8.00%, which indicates a significant decrease from 8.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2975 in the past 14 days, which was higher than the 0.2325 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.8026, while its 200-day Moving Average is $3.1118. Now, the first resistance to watch is $1.7017. This is followed by the second major resistance level at $1.7933. The third major resistance level sits at $1.9517. If the price goes on to break the first support level at $1.4517, it is likely to go to the next support level at $1.2933. Now, if the price goes above the second support level, the third support stands at $1.2017.
Eledon Pharmaceuticals Inc (NASDAQ: ELDN) Key Stats
The company with the Market Capitalisation of 120.88 million has total of 59,932K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -36,180 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -17,460 K.
